Can AI enhance and accelarate human evolution ?

What would it mean to use artificial intelligence to enhance and speed up human evolution? Today’s AI can already accelerate biomedical breakthroughs—like modeling protein structures or optimizing CRISPR therapies—but can it truly alter the trajectory of human biology, or does it merely accelerate the tools we use to study it?

Background

AI’s role in biomedical research spans multiple fronts: AlphaFold has revolutionized protein folding prediction by using deep learning to model 3D structures from amino-acid sequences, achieving near-experimental accuracy on large protein families; this in turn accelerates the identification of beneficial mutations and non-synonymous variants across genomes (Senior et al., Nature 2020; Jumper et al., Nature 2021). Machine-learning models trained on population-scale GWAS and exome data (e.g., UK Biobank and gnomAD) now prioritize candidate alleles for polygenic traits and disease risk, enabling faster hypothesis generation for follow-up functional studies (Zhou & Troyanskaya, Cell 2015; Karczewski et al., Nature 2020). In therapeutic design, deep generative models generate optimized CRISPR single-guide RNAs and prime editing templates, reducing the experimental search space and increasing on-target efficiency by up to 2–5× in early benchmarks (Haque et al., bioRxiv 2023; Lun et al., Nat Biotechnol 2022). Beyond gene editing, AI-driven closed-loop deep brain stimulation and non-invasive BCIs (e.g., Neuralink’s N=1 feasibility studies) demonstrate real-time decoding of motor intent and memory encoding, with early reports showing motor function recovery gains in tetraplegic patients (Widge et al., Nat Biomed Eng 2022; Chaudhary et al., Nat Biomed Eng 2021). These augmentation pathways are somatic and reversible; germ-line editing and heritable modifications remain ethically constrained under frameworks such as the WHO Human Genome Editing Registry and the International Commission on Human Gene Editing’s 2020 guidance, which endorses somatic editing while placing moratoria on heritable human genome modifications pending broad societal consensus.